SOURCE: Althea Technologies, Inc.

July 07, 2008 06:00 ET

Althea Technologies Signs Accord With Protein'eXpert, SA to Expand Development and Manufacturing Services

SAN DIEGO, CA--(Marketwire - July 7, 2008) - Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has signed a Letter of Intent to establish a complementary commercialization partnership with Protein'eXpert (Grenoble, France). Protein'eXpert is a Contract Research Organization devoted to recombinant protein engineering and production for biomedical research applications focusing on optimization of valuable target or therapeutic proteins. The agreement stems from the introduction of the firms through the Lyonbiopôle and Invest in France Agency initiatives in the United States.

The agreement provides for the pairing of each company's highly complementary expertise to better serve the growing biopharmaceutical development markets and extends the global commercial activities of each firm, particularly in Europe and the United States. Clients will gain access to Protein'eXpert's advanced protein engineering, process development and optimization expertise, with the full realm of cGMP manufacturing resources for production and Fill/Finish services from phase I clinical to commercial manufacturing provided by Althea. These complementary service offerings will allow both companies to reach larger markets, broaden services for new and challenging products and to better match early and late stage client requirements for protein projects.

"The partnership with Althea Technologies is a great opportunity for us. Their very strong position on the US market and their outstanding production facilities shall perfectly complement our expertise and set of services based on Recombinant protein engineering, development and small scale cGMP production," says Dr. Tristan Rousselle, CEO of Protein'eXpert.

"We are very pleased to enter this agreement with Protein'eXpert. Their highly regarded science and service standards are a wonderful complement to Althea's manufacturing services. We are confident that this will strengthen Althea's presence in Europe and provide Althea clients valuable early stage process development capabilities," stated Dr. Magda Marquet, President and Co-CEO of Althea Technologies.

"We have been working with Althea Technologies for several months to develop the optimal solution for its business in France," said Alexandre Thermet, Vice President of Invest in France Agency -- North America. "The level of expertise and innovation offered by the Lyonbiopôle cluster, in addition to recent incentives implemented by the French government, led us to identify Protein'eXpert as an ideal partner for Althea Technologies. We will continue to work with Althea to ensure that they fully benefit from the range of advantages France is currently offering companies in their field."

About Althea Technologies, Inc.

Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea's services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, and aseptic filling. For more information, visit

About Protein'eXpert, SA.

Located in Grenoble (France), Protein'eXpert provides integrated protein therapeutics and vaccines development contract services. Recognized as a leading European player in the recombinant protein field, Protein'eXpert offers early stage development programme including protein engineering, process development and small scale cGMP manufacturing services. For more information, visit

Contact Information

  • Contact:

    Althea Technologies, Inc.
    Alan Moore
    Executive Vice President and
    Chief Business Officer
    (858) 882-0205
    Email Contact